-
-
-
-
-
-
-
Nuvation Bio reports $24.7 million in revenue for cancer drug IBTROZI
-
-
-
-
-
-
-
Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025
-
-
-
-
-
-
-
Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 1c
-
-
-
-
-
-
-
Nuvation Bio Inc. (NUVB) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

